Agilent Technologies Inc at Goldman Sachs Healthcare CEOs Unscripted Conference (Virtual) Transcript
Good afternoon, everyone, and Happy New Year. I'm Matt Sykes, the life science tools and diagnostics analyst for Goldman Sachs, and I have the pleasure of welcoming Mike McMullen, CEO; and Bob McMahon, CFO of Agilent, here today. Mike and Bob, thanks so much for joining us today. We really appreciate the time.
I thought I'd let you guys set the stage for us in the first few minutes and talk about the year review for Agilent. What were some of the challenges and opportunities presented by COVID? And then what parts of the business are you most excited about for 2021? And kind of how did the 2020 finish up? And what does the momentum look like as we head into the new year?
Sure, Matt. And first of all, thanks for the invitation to join today's conference, and Happy New Year to the audience, and thank you for joining us here as well.
So 2020, as we all know, will go down as a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
